文献速递关节外科

无髌骨关节炎患者全膝关节置换术中常规髌骨置换不符合成本效益

Routine Patellar Resurfacing During Total Knee Arthroplasty Is Not Cost-Effective in Patients Without Patellar Arthritis.
PubMed 文献 · J Arthroplasty · 2019-04-26

该研究通过文献综述纳入14项前瞻性随机研究、3,562例患者共3,823例全膝关节置换,比较常规与选择性髌骨置换的成本效用。结果显示未置换组术后持续性膝前痛20.9% vs 置换组13.2%(P<.001),再手术率3.7% vs 1.6%(P<.001);仅分析无髌骨关节炎研究时,每增加1个质量调整生命年的增量成本为183,584美元。作者认为对无关节炎的髌骨常规置换不符合成本效益。

要点

  • 未置换组持续性膝前痛20.9% vs 置换组13.2%(P<.001)。
  • 未置换组髌骨再手术3.7% vs 置换组1.6%(P<.001)。
  • 无髌骨关节炎研究中,髌骨置换每增加1个QALY的增量成本为183,584美元。

核心结论

  • 利用新的前瞻性随机研究数据,本分析发现全膝关节置换中对无关节炎的髌骨进行常规置换不符合成本效益。
  • 髌骨置换在全膝关节置换中仍是一个有争议的问题。

研究设计与样本

  • 通过文献综述识别比较全膝关节置换中髌骨置换与不置换的前瞻性随机研究。
  • 文献综述共纳入14项研究,3,562例患者接受3,823例全膝关节置换,其中1,873例(49.0%)髌骨被置换。
  • 使用既往验证的McKnee改良健康效用指数效用评分,为每种潜在结局提供终点效用值。

主要发现

  • 未置换组与置换组术后持续性膝前痛分别为20.9% vs 13.2%(P<.001)。
  • 未置换组与置换组髌骨再手术分别为3.7% vs 1.6%(P<.001)。
  • 在排除髌骨关节炎患者的研究中,两组膝前痛发生率相当,再手术率分别为1.2% vs 0%(P=.06)。
  • 髌骨置换对选择性及无差别髌骨置换均提供边际改善的质量调整生命年(QALY)。
  • 纳入所有研究时,每QALY增量成本为3,032美元;仅分析无髌骨关节炎研究时,髌骨置换的每QALY增量成本增至183,584美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Currently, the decision to resurface the patella is often made irrespective of the presence of patellar arthritis. The purpose of this study is to utilize the existing literature to assess cost-utility of routinely vs selectively resurfacing the patella. METHODS: Prospective randomized studies of patella resurfacing vs non-resurfacing in total knee arthroplasty (TKA) were identified through literature review. Data from these studies represented probabilities of varied outcomes following TKA dependent upon patella resurfacing. Using previously validated utility scores from the McKnee modified Health Utilities Index, endpoint utility values were provided for each potential outcome. RESULTS: Literature review yielded a total of 14 studies with 3,562 patients receiving 3,823 TKAs, of which 1,873 (49.0%) patellae were resurfaced. Persistent postoperative anterior knee pain occurred in 20.9% vs 13.2% (P < .001) and patella reoperation was performed in 3.7% vs 1.6% (P < .001) of unresurfaced and resurfaced patella, respectively. In studies excluding those with arthritic patellae, the incidence of anterior knee pain was equivalent between groups and reoperation decreased to 1.2% vs 0% (P = .06). Patella resurfacing provided marginally improved quality-adjusted life-years (QALY) for both selective and indiscriminate patella resurfacing. When including all studies, the incremental cost per QALY was $3,032. However, when analyzing only those studies with nonarthritic patellae, the incremental cost per QALY to resurface the patella increased to $183,584. CONCLUSION: Patellar resurfacing remains a controversial issue in TKA. Utilizing data from new prospective randomized studies, this analysis finds that routinely resurfacing arthritis-free patellae in TKA are not cost-effective.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zmistowski BM, Fillingham YA, Salmons HI, et al. Routine Patellar Resurfacing During Total Knee Arthroplasty Is Not Cost-Effective in Patients Without Patellar Arthritis. J Arthroplasty. 2019. PMID: 31104838. doi:10.1016/j.arth.2019.04.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。